Frequency and etiology of pulmonary hypertension in patients with myeloproliferative neoplasms
ConclusionIn the largest study ever reported, we found a lower prevalence of PH (3.8%) than previously reported. Screening for PH in unselected MPN patients is not justified.This article is protected by copyright. All rights reserved.
Source: European Journal of Haematology - Category: Hematology Authors: Mette Brabrand,
Knud N ørregaard Hansen,
Christian B. Laursen,
Thomas Stauffer Larsen,
Hanne Vestergaard,
Niels Abildgaard Tags: Original Article Source Type: research
More News: Cardiac Catheterization | Cardiology | Heart | Hematology | Hypertension | Myeloproliferative Disorders | Pulmonary Hypertension | Study